Easy-to-use test that provides results in 15 minutes is now available without a prescription The Sofia® SARS Antigen FIA shows excellent performance within the first five days of the onset of symptoms ...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ:QDEL), a leader in point-of-care (POC) rapid diagnostic tests, today announced recent initiatives to educate and inform the healthcare community ...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the ...

SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

The stock's recent weakness is probably due to a high-profile case calling into question the specificity of Quidel's rapid antigen test. I explore the potential ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Summer is time for camp—but it's also prime season for Lyme disease. That's the reminder from diagnostic maker Quidel, which has launched an awareness campaign highlighting the rise and risk of the ...

Quidel recorded its best-ever revenue performance in 2021 at $1.699 billion despite its gross profit falling to $1.271 billion YOY. The fairly priced QuickVue At-Home OTC gave Quidel the impetus to ...

Fa. Abbott Laboratories GmbH in Neustadt a. R. bei Hannover (Photo by Rust/ullstein bild via Getty Images) Quidel, a company that makes diagnostic products for infectious diseases and other conditions ...

The rapid tests, which are only 80 to 90 percent accurate, have not stopped a coronavirus outbreak AFP / Alberto PIZZOLI Quidel has recalled several lots of its COVID tests because they produce ...

Quidel is recalling its Lyra SARS-CoV-2 Assay due to a high risk of false negative results. "False negative results may lead to delayed diagnosis or inappropriate treatment of SARS-CoV-2 that may ...